Technology | June 16, 2009

Discovery PET/CT 690 for Exploration

Discovery PET/CT 600

As Discovery PET/CT 600 series continues to expand, GE Healthcare introduced the Discovery PET/CT 690 – a molecular imaging tool designed go beyond the needs of the clinical practice and provide the necessary tools and technologies to explore the future of PET/CT imaging.

The Discovery PET/CT 690 was built with the academic in mind. The breakthrough scanner allows for improved quantitative accuracy and the reconstruction power needed to explore the potential of PET/CT imaging. The new system leverages the high-speed, high-resolution capabilities of GE’s LightSpeed VCT. Combining the innovative molecular imaging platform with GE’s advanced volume CT and Discovery Dimension console technologies, the Discovery PET/CT 690 provides users with answers to flexibility, time, accuracy and motion.

With a unique detector configuration designed for sensitivity and efficiency, researchers and clinicians have the necessary speed in workflow and protocol flexibility to help explore new frontiers in clinical techniques, drug discovery and motion management.

The Discovery PET/CT 690 includes the exclusive IBM BladeCenter, where users have the ability to reconstruct PET images in minutes instead of hours, potentially improving workflow of detailed studies.

GE’s breakthrough VUE Point FX, the next generation in high-definition reconstruction, provides state of the art performance and unique timing resolution stability.

Like all of the Discovery PET/CT 600 Series products, he 690 incorporates MotionFree imaging technologies into the clinical workflow. This technology has the potential to improve small lesion detection and image quality when coupled with MotionFree techniques, especially in areas affected by patient motion. Leveraging the coincidence timing capabilities of the Discovery PET/CT 690, VUE Point FX incorporates time-of-flight acquisitions into the VUE Point HD 3D iterative process, providing for image quality improvements in PET/CT scan modes.

With the Discovery PET/CT 690, imagers can take advantage of advanced reconstruction and motion techniques at a routine pace. GE's next generation of MotionFree imaging technologies on the new Discovery PET/CT 690 are designed to give clinicians detailed images even in areas of the body subject to movement caused by respiration and cardiac movement. The scanner’s techniques address motion challenges including artifacts, blurring and quantification. With the MotionFree suite components, Motion Match to align the PET and CT gated studies, and Motion VUE to improve the reading of motion studies, motion management can be incorporated in research protocols. Users now have the ability to further diagnose and stage with accuracy, plan with precision and monitor with confidence.

With specialized detector configuration designed for sensitivity, event throughput and efficiency, researchers and clinicians have the necessary speed in workflow, protocol flexibility and unique timing resolution technology to help forge new frontiers in clinical techniques, drug discovery and motion management.

The Discover PET/CT 690 was released in 2009.

For more information: www.gehealthcare.com

Related Content

Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
FDG-PET/CT Predicts Melanoma Patients' Response to Immune Checkpoint Inhibitor Therapy
News | PET-CT | September 07, 2017
September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective
Sponsored Content | Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging | August 18, 2017
August 18, 2017 — The American Society of Nuclear Cardiology (ASNC) has released a joint expert consensus document wi
PET/CT Tracer Identifies Vulnerable Lesions in Non-Small Cell Lung Cancer Patients

Example of a patient with an upper left lung NSCLC: A: FDG; B: FDG PET/CT; C: Planning radiotherapy based on FDG (66Gy) with BTVm (GTV), CTV and PTV; D: PET FMISO E: FMISO PET/CT; F: boost based on the FMISO PET (76Gy) with BTVh (biological hypoxic target volume) and PTV boost. Credit: QuantIF – LITIS EA 4108 – FR CNRS 3638, Henri Becquerel Cancer Center, Rouen, France

News | PET-CT | July 14, 2017
July 14, 2017 — Fluorine-18 (18F)-fluoromisonidazole (FMISO) is a positron emission tomography (PET)...
A 77-year-old male with recurrent lymph node and pulmonary metastases detected by Ga-68 PSMA PET/CT but not by conventional imaging

A 77-year-old male with recurrent lymph node and pulmonary metastases detected by Ga-68 PSMA PET/CT but not by conventional imaging. Graphic courtesy of the Department of Nuclear Medicine, Royal North Shore Hospital, Sydney

News | Prostate Cancer | June 15, 2017
An estimated one in seven American men will be affected by prostate cancer in their lifetime. Prostate-specific...
Overlay Init